These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 24131087)
1. Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations. Dieplinger G; Ditt V; Arns W; Huppertz A; Kisner T; Hellmich M; Bauerfeind U; Stippel DL Transpl Int; 2014 Jan; 27(1):60-8. PubMed ID: 24131087 [TBL] [Abstract][Full Text] [Related]
2. De novo donor specific antibodies and patient outcomes in renal transplantation. DeVos JM; Patel SJ; Burns KM; Dilioglou S; Gaber LW; Knight RJ; Gaber AO; Land GA Clin Transpl; 2011; ():351-8. PubMed ID: 22755430 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts. Cooper JE; Gralla J; Chan L; Wiseman AC Clin Transpl; 2011; ():359-64. PubMed ID: 22755431 [TBL] [Abstract][Full Text] [Related]
4. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death. Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534 [TBL] [Abstract][Full Text] [Related]
5. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation. Li X; Ishida H; Yamaguchi Y; Tanabe K Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618 [TBL] [Abstract][Full Text] [Related]
6. Luminex Solid-Phase Crossmatch for De Novo Donor-Specific Antibodies in Living-Donor Related Transplants. Mehrotra S; Sharma RK; Mayya M; Gupta A; Prasad N; Kaul A; Bhadauria DS Exp Clin Transplant; 2017 Aug; 15(4):394-399. PubMed ID: 28447925 [TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation. Caro-Oleas JL; González-Escribano MF; Gentil-Govantes MÁ; Acevedo MJ; González-Roncero FM; Blanco GB; Núñez-Roldán A Transplantation; 2012 Aug; 94(4):338-44. PubMed ID: 22814330 [TBL] [Abstract][Full Text] [Related]
8. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules. Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902 [TBL] [Abstract][Full Text] [Related]
9. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation. Thiyagarajan UM; Bagul A; Frost J; Horsburgh T; Nicholson ML Transplant Proc; 2012 Jun; 44(5):1231-5. PubMed ID: 22663991 [TBL] [Abstract][Full Text] [Related]
10. Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing. Süsal C; Wettstein D; Döhler B; Morath C; Ruhenstroth A; Scherer S; Tran TH; Gombos P; Schemmer P; Wagner E; Fehr T; Živčić-Ćosić S; Balen S; Weimer R; Slavcev A; Bösmüller C; Norman DJ; Zeier M; Opelz G; Transplantation; 2015 Sep; 99(9):1976-80. PubMed ID: 25769065 [TBL] [Abstract][Full Text] [Related]
11. Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies. Kubal C; Mangus R; Saxena R; Lobashevsky A; Higgins N; Fridell J; Tector AJ Transplantation; 2015 Aug; 99(8):e49-56. PubMed ID: 25769071 [TBL] [Abstract][Full Text] [Related]
12. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes. Freitas MC; Rebellato LM; Ozawa M; Nguyen A; Sasaki N; Everly M; Briley KP; Haisch CE; Bolin P; Parker K; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI Transplantation; 2013 May; 95(9):1113-9. PubMed ID: 23514959 [TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation. Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767 [TBL] [Abstract][Full Text] [Related]
17. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
18. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay. Phelan D; Mohanakumar T; Ramachandran S; Jendrisak MD Hum Immunol; 2009 Aug; 70(8):584-8. PubMed ID: 19477211 [TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter? Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088 [TBL] [Abstract][Full Text] [Related]
20. Early Intervention in Living Kidney Transplantation Based on Dynamic Monitoring of Donor Specific Antibodies. Chen Y; Li LY; Lou XY; Wang H; Zhang L; Zhu YH Clin Transpl; 2014; ():205-8. PubMed ID: 26281146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]